July 10, 2020

The Niche

Knoepfler lab stem cell blog

Search Results for: patient deaths

2 min read

The FDA recently issued a lengthy warning letter to Northwestern University over the clinical trial practices of its Dr. Richard Burt and this letter just popped up on the FDA website. To my knowledge this is an unprecedented event as I’m not aware of another warning letter to a major university for a stem cell trial. Burt received the FDA warning letter late last year for a number of serious problems with his stem cell trial including failure to promptly report patient deaths to the FDA. Another issue noted …Read More

6 min read

What is the role of public education and stem cell tourism? What type of education is available to patients, caregivers and the public? Can public education actually change people’s minds such that they won’t undergo an unproven stem cell-based intervention (SCBI)? These are the questions I will discuss here. But first, let’s just give a brief description of stem cell tourism and outline some of the proposals discussed to stop this industry. The “Stem Cell Tourism” Industry and Ways to Curtail the Market Briefly, …Read More

2 min read

The Philippines Medical Association (PMA) is reportedly (article from ABS-CBN News) investigating the recent deaths of 3 prominent politicians due to stem cell therapies via stem cell tourism in Germany at an as yet unidentified clinic. The names of the politicians are unknown, but strangely enough today there’s another separate article on stem cells from the Philippine Daily Inquirer that mentions 3 politicians who have received stem cell treatments: A number of politicians have been reported to have used stem cell therapy, including former President Joseph Estrada, …Read More

3 min read

“HSCT Chicago Clinic Closing!” is the startling header in all caps on a patient-run Facebook page about a stem cell therapy clinical trial program at Northwestern University. What’s going on? Unfortunately, the promising field of hematopoietic stem cell transplantation (HSCT) for multiple sclerosis (MS) and other autoimmune diseases seems to have suffered an unexpected setback here. Dr. Richard Burt of Northwestern, one of the leading figures in the area of developing HSCT approaches for MS and other autoimmune disorders, is going on a sabbatical …Read More